Long-term safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), a novel orally administered combination endectocide for dogs
Kari L Riggs, Xinshuo Wang, Scott Wiseman · 2025
Read Long-term safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), a novel orally administered combination endectocide for dogs by Kari L Riggs, Xinshuo Wang, Scott Wiseman (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12821975.txt.
Description
Kari Riggs, Xinshuo Wang, and Scott Wiseman report, in a 2025 study, a long-term safety test of a four-in-one chewable tablet for dogs. The tablet pairs four parasite drugs to give a month of cover against worms and other pests after one dose. Before such a product can be sold, its safety at and above the label dose must be proven.
Thirty-two beagle puppies, eight weeks old, were split into four groups. One group got dummy tablets, and the others got the real tablet at one, three, or five times the top label dose, nine times in all, each time after food. Checks covered health, weight, blood and urine tests, and tissue exams. No serious treatment-linked harm appeared, the team report.
Catalog record
| CREATOR | Kari L Riggs, Xinshuo Wang, Scott Wiseman |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |